ALKS 5461

Showing 1 posts of 1 posts found.

Phase III depression trial success for Alkermes

October 24, 2016
Research and Development, Sales and Marketing ALKS 5461, Alkermes, major depressive disorder

Biopharma company Alkermes has announced the success of its ALKS 5461 treatment in a Phase III study for the treatment …

The Gateway to Local Adoption Series

Latest content